Asthma  >>  Dulera (mometasone/formoterol)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dulera (mometasone/formoterol) / Merck (MSD), Novartis
SPIRO, NCT01471340 / 2011-002142-13: A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)

Completed
4
11744
NA
Mometasone Furoate/Formoterol MDI 100/5 mcg, MK-0887A; Dulera/Zenhale, Mometasone Furoate/Formoterol MDI 200/5 mcg, Mometasone Furoate MDI 100 mcg, Asmanex, Mometasone Furoate MDI 200 mcg, Albuterol 90 mcg /salbutamol 100 mcg HFA MDI, Prednisone/prednisolone
Organon and Co
Asthma
11/16
11/16
NCT02045875: Improving Asthma Control in the Real World: A Systematic Approach to Improving Dulera Adherence

Completed
4
50
US
Dulera, mometasone furoate/formoterol fumarate dihydrate
Asthma Management Systems, Merck Sharp & Dohme LLC, West Penn Allegheny Health System
Asthma
07/17
07/17

Download Options